| 产品详情 |
| Edit |   |
|---|
| Product Name | Kenpaullone |
|---|
| Description | Purity >98%. The development of selective, cell-permeable protein kinase inhibitors for the treatment of cancer, inflammation, and other diseases, is a major focus of drug development efforts. Kenpaullone is an ATP-competitive inhibitor of several cyclin-dependent kinases (CDKs) as well as glycogen synthase kinase 3Beta (GSK3Beta). It inhibits GSK3Beta with an IC50 value of 0.023 µM3 (0.23 µM)2 and Cdk1/cyclin B, Cdk2/cyclin A, Cdk5/p25, and lymphocyte kinase with IC50 values of 0.4, 0.68, 0.85, and 0.47 µM, respectively. |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 9-bromo-7,12-dihydro-indolo[3,2-d][1]benzazepin-6(5H)-one, 9-Bromopaullone, NSC 664704 |
|---|
| Gene, Accession, CAS # | CAS: 142273-20-9 |
|---|
| Catalog # | LS-H8337 |
|---|
| Price | |
|---|
| Order / More Info | Kenpaullone from LIFESPAN BIOSCIENCES INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|